Document is current

Article History

Received: 12 December 2022

Accepted: 5 April 2023

First Online: 2 May 2023

Declarations

:

: Not applicable.

: All authors accept and confirm publication.

: Dr. Brodie receives research support from and consults for LivaNova. He has been on the medical advisory boards for Abiomed, Xenios, Medtronic, Inspira, and Cellenkos. He is the President-elect of the Extracorporeal Life Support Organization (ELSO) and the Chair of the Executive Committee of the International ECMO Network (ECMONet). Dr. Rayan Barbaro is the Extracorporeal Life Support Organization (ELSO) Registry Chair and receives support unrelated to this work from the National Institutes of Health R01 HL153519; K12 HL138039. Dr. Alain Combes reports grants from Getinge and personal fees from Getinge, Baxter, and Xenios outside the submitted work. Dr. Akram Abdelbary received lecture fees and educational fees from Gettinge, Pfizer, Sanofi, Novartis, Bayer not related to this work. Dr. Graeme serves as global representative on the Board of Directors of ELSO. All authors declared no conflict of interest related to this work.